Literature DB >> 27688472

Evaluation of Spleen Glucose Metabolism Using 18F-FDG PET/CT in Patients with Febrile Autoimmune Disease.

Sung Soo Ahn1, Sang Hyun Hwang2, Seung Min Jung1, Sang-Won Lee1, Yong-Beom Park1, Mijin Yun3, Jason Jungsik Song4.   

Abstract

The purpose of this study was to evaluate the clinical significance of 18F-FDG uptake by the spleen in patients with autoimmune disease.
Methods: We retrospectively reviewed Severance Hospital's electronic medical records of patients hospitalized for the evaluation of fever who underwent 18F-FDG PET/CT. We found 91 patients with autoimmune diseases and 101 patients with localized infection. 18F-FDG uptake was assessed by measuring SUV in the spleen and liver. The spleen-to-liver ratio of the SUVmean (SLRmean) was calculated. Clinical and laboratory parameters were collected and evaluated for association with SLRmean In-hospital mortality was defined as all-cause mortality during hospital admission for fever.
Results: SLRmean was significantly higher in autoimmune disease than in localized infectious disease (1.28 ± 0.43 vs. 0.91 ± 0.21, P < 0.001). In autoimmune disease, SLRmean was correlated with monocytes, aspartate aminotransferase, alanine aminotransferase, albumin, and ferritin. Analysis of receiver-operating-characteristic curves revealed that in comparison with laboratory parameters, SLRmean had the highest performance in differentiating autoimmune from localized infectious disease. Multivariate logistic regression analysis demonstrated that high SLRmean and low platelets were significantly associated with in-hospital mortality in febrile autoimmune disease.
Conclusion: These findings suggest that spleen glucose metabolism is increased in febrile autoimmune disease. Spleen 18F-FDG uptake may provide information useful in differentiating febrile autoimmune disease from localized infectious disease and predicting clinical outcomes in febrile autoimmune disease.
© 2017 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  18F-FDG PET/CT; autoimmune disease; bone marrow; immunometabolism; spleen

Mesh:

Substances:

Year:  2016        PMID: 27688472     DOI: 10.2967/jnumed.116.180729

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  11 in total

1.  The clinical utility of splenic fluorodeoxyglucose uptake for diagnosis and prognosis in patients with macrophage activation syndrome.

Authors:  Sung Soo Ahn; Sang Hyun Hwang; Seung Min Jung; Sang-Won Lee; Yong-Beom Park; Mijin Yun; Jason Jungsik Song
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

2.  Internal tissue references for 18Fluorodeoxyglucose vascular inflammation imaging: Implications for cardiovascular risk stratification and clinical trials.

Authors:  Mark A Ahlman; Davis M Vigneault; Veit Sandfort; Roberto Maass-Moreno; Jenny Dave; Ahmed Sadek; Marissa B Mallek; Mariana A F Selwaness; Peter Herscovitch; Nehal N Mehta; David A Bluemke
Journal:  PLoS One       Date:  2017-11-13       Impact factor: 3.240

3.  Tissue-resident NK cells differ in their expression profile of the nutrient transporters Glut1, CD98 and CD71.

Authors:  Wilhelm Salzberger; Gloria Martrus; Kai Bachmann; Hanna Goebels; Leonard Heß; Martina Koch; Annika Langeneckert; Sebastian Lunemann; Karl J Oldhafer; Caroline Pfeifer; Tobias Poch; Laura Richert; Christoph Schramm; Ramez Wahib; Madeleine J Bunders; Marcus Altfeld
Journal:  PLoS One       Date:  2018-07-20       Impact factor: 3.240

4.  Clinical utility of FDG uptake within reticuloendothelial system on F-18 FDG PET/CT for prediction of tumor recurrence in breast cancer.

Authors:  Ji-In Bang; Hai-Jeon Yoon; Bom Sahn Kim
Journal:  PLoS One       Date:  2018-12-07       Impact factor: 3.240

5.  Development and Validation of a Nomogram Based on 18F-FDG PET/CT Radiomics to Predict the Overall Survival in Adult Hemophagocytic Lymphohistiocytosis.

Authors:  Xu Yang; Jun Liu; Xia Lu; Ying Kan; Wei Wang; Shuxin Zhang; Lei Liu; Hui Zhang; Jixia Li; Jigang Yang
Journal:  Front Med (Lausanne)       Date:  2021-12-22

6.  Predicting treatment outcomes using 18F-FDG PET biomarkers in patients with non-small-cell lung cancer receiving chemoimmunotherapy.

Authors:  Chang Gon Kim; Sang Hyun Hwang; Kyung Hwan Kim; Hong In Yoon; Hyo Sup Shim; Ji Hyun Lee; Yejeong Han; Beung-Chul Ahn; Min Hee Hong; Hye Ryun Kim; Byoung Chul Cho; Arthur Cho; Sun Min Lim
Journal:  Ther Adv Med Oncol       Date:  2022-01-09       Impact factor: 8.168

7.  Differential Diagnosis of Hemophagocytic Syndrome by 18F-FDG PET/CT: A Meta-Analysis.

Authors:  Jun Zhang; Bang He; Jian Wang; Caiyun Ying; Lingfeng Zeng; Shiyi Zheng
Journal:  J Healthc Eng       Date:  2022-01-29       Impact factor: 2.682

8.  Lymphopenia in patients affected by SARS-CoV-2 infection is caused by margination of lymphocytes in large bowel: an [18F]FDG PET/CT study.

Authors:  Alberto Signore; Chiara Lauri; Marzia Colandrea; Marco Di Girolamo; Erika Chiodo; Chiara Maria Grana; Giuseppe Campagna; Antonio Aceti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-04-29       Impact factor: 10.057

9.  Clinical implications of increased uptake in bone marrow and spleen on FDG-PET in patients with bacteremia.

Authors:  Jordy P Pijl; Thomas C Kwee; Riemer H J A Slart; Derya Yakar; Marjan Wouthuyzen-Bakker; Andor W J M Glaudemans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-10-26       Impact factor: 9.236

10.  COVID-19 pneumonia: relationship between inflammation assessed by whole-body FDG PET/CT and short-term clinical outcome.

Authors:  Matthieu Dietz; Gilles Chironi; Yann-Erick Claessens; Ryan Lukas Farhad; Isabelle Rouquette; Benjamin Serrano; Valérie Nataf; Florent Hugonnet; Benoît Paulmier; Frédéric Berthier; Olivia Keita-Perse; Francesco Giammarile; Christophe Perrin; Marc Faraggi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-07-25       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.